Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease

Published:2017-02-06 Issue:3 Volume:26 Page:319-329
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Malerba Mario¹,Radaeli Alessandro²,Montuschi Paolo³,Babu Kesavan S.⁴,Morjaria Jaymin B⁵

Affiliation:

1. Department of Internal Medicine, University of Brescia and ASST Spedali Civili, Brescia, Italy

2. Department of Emergency, ASST Spedali Civili, Brescia, Italy

3. Department of Pharmacology, Faculty of Medicine, University Hospital Agostino Gemelli Foundation Catholic University of the Sacred Heart, Pharmacology, Rome, Italy

4. Department of Respiratory Medicine, Queen Alexandra Hospital, Cosham, Portsmouth, UK

5. Department of Respiratory Medicine, Royal Brompton & Harefield NHS Trust, Harefield Hospital, Harefield, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1287172

Reference66 articles.

1. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

2. Triple inhaled therapy for chronic obstructive pulmonary disease

3. An update on bronchodilators in Phase I and II clinical trials

4. Novel anti-cholinergics in COPD

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Availability of drugs for the treatment of chronic obstructive pulmonary disease in the Republic of Moldova;Farmacist.ro;2024

Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease

;Journal of Experimental Pharmacology;2020-12

3. Fixed‐dose combination of umeclidinium and vilanterol for patients with chronic obstructive pulmonary disease: A systematic review;The Clinical Respiratory Journal;2019-09-02